Role of Endothelial Progenitor Cells in Vascular Dysfunction
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 30 September 2026 | Viewed by 17
Special Issue Editor
Interests: cardiometabolic disorders; developmental programming; endothelial progenitor cells; oxidative stress; cellualr senescence; cellular therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular disease (CVD) remains one of the leading causes of mortality worldwide, affecting populations in both developed and developing countries. Many forms of CVD, including atherosclerosis, arterial hypertension, and chronic heart failure, are closely associated with endothelial dysfunction, which reduces arterial elasticity and contributes to disease progression.
Endothelial progenitor cells (EPCs) are circulating components derived from the bone marrow that play a critical role in maintaining vascular integrity. Once mobilized, EPCs differentiate into mature endothelial cells and secrete various bioactive molecules and growth factors that support vasculogenesis and vascular homeostasis. EPCs can be classified based on their phenotype and in vivo function. Early EPCs, which are of hematopoietic origin, facilitate angiogenesis primarily through paracrine signaling but lack the ability to form mature endothelial cells. In contrast, late EPCs, also known as endothelial colony-forming cells (ECFCs), possess clonal potential and can proliferate, self-renew, migrate, differentiate, and promote vascular growth and neovascularization both in vitro and in vivo.
Reduced number and impaired function of EPCs are commonly observed in patients with CVD and may serve as predictive biomarkers for cardiovascular events. Dysfunctional EPCs have also been identified in individuals with low birth weight due to preterm birth or intrauterine growth restriction. Factors such as inflammation, oxidative stress, and cellular senescence negatively affect EPC function, whereas interventions such as statin therapy, antioxidant treatment, polyphenol intake, and physical exercise can enhance their activity. Given their regenerative potential, EPCs have recently been investigated for use in cell-based therapies for restoring endothelial integrity and promoting neovascularization in ischemic tissues across both animal models and clinical studies.
Dr. Catherine Yzydorczyk
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular diseases
- endothelial progenitor cells
- vasculogenesis
- angiogenesis
- inflammation
- oxidative stress
- cellular senescence
- developmental programming
- cellular therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
